| 摘要 |
<p>The present invention relates to the compound of formula (I): or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof. This compound of formula (I) is conveniently called: (E)-7[4-(4-fluorophenyl)-6-isopropyl-2-mesylaminopyrimidin-5-yl]-(3R,5S)-dihydroxyhept-6-enoic acid.</p> |
